欧洲生物信息学市场 – 2029 年行业趋势和预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲生物信息学市场 – 2029 年行业趋势和预测

  • Medical Devices
  • Published Report
  • Aug 2022
  • Europe
  • 350 页面
  • 桌子數: 295
  • 图号: 48

Europe Bioinformatics Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2029
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD 1,459.71 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • QIAGEN
  • SOPHiA GENETICS

>欧洲生物信息学市场,按类型(知识管理工具、生物信息学软件和服务)、部门(医学生物技术、学术、动物生物技术、农业生物技术、环境生物技术、法医生物技术等)、应用(基因组学和药物开发、蛋白质组学、进化研究、农业研究、兽医学、代谢组学、转录组学等)、购买模式(团购和个人购买)、方法(基因组学和蛋白质组学)最终用户(研究和学术机构、临床研究组织、生物技术和制药公司、研究实验室、医院等)划分 - 行业趋势和预测到 2029 年。

生物信息学市场

欧洲生物信息学市场分析与洞察

推动生物信息学市场增长的因素包括:每个碱基的基因测序成本较低、对生物信息学的需求不断增长、主要市场参与者提供的产品组合广泛、生物信息学在个性化医疗中的应用以及公共和私营部门对生物信息学的资助增加。然而,预计会限制市场增长的因素包括仪器成本的上升、临床生物信息学分析的难度以及生物信息学的网络安全。

生物信息学市场

生物信息学市场

另一方面,市场参与者的战略举措、产品开发、生物信息学技术的进步以及医疗保健支出的增加可能为生物信息学市场的增长提供机会。然而,对熟练专业知识的需求、在临床实验室实施生物信息学技术的挑战以及监管部门的批准可能会给生物信息学市场带来挑战。最近出现了与全球生物信息学市场相关的发展。

欧洲生物信息学研发活动的增加预计将推动市场增长。Data Bridge Market Research 分析称,在 2022 年至 2029 年的预测期内,欧洲生物信息学市场将以 19.5% 的复合年增长率增长。

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制至 2019 - 2014)

定量单位

收入(百万美元),定价(美元)

涵盖的领域

按类型(知识管理工具、生物信息学软件和服务)、部门(医学生物技术、学术、动物生物技术、农业生物技术、环境生物技术、法医生物技术等)、应用(基因组学和药物开发、蛋白质组学、进化研究、农业研究、兽医学、代谢组学、转录组学等)、购买模式(团购和个人购买)、方法(基因组学和蛋白质组学)最终用户(研究和学术机构、临床研究组织、生物技术和制药公司、研究实验室、医院等)

覆盖国家

德国、法国、英国、意大利、俄罗斯、西班牙、瑞士、荷兰、比利时、土耳其、欧洲其他地区

涵盖的市场参与者

Thermo Fisher Scientific Inc.、Illumina, Inc.、安捷伦科技公司、QIAGEN、SOPHiA GENETICS.、BGI、Eurofins Scientific、Waters Corporation、Dassault Systèmes、拜耳公司、PerkinElmer Inc.、Seven Bridges Genomics、Quest Diagnostics Incorporated.、AstridBio Technologies Inc.、BioBam 和 GenoFAB, Inc.

市场定义

生物信息学结合了计算机编程、大数据和分子生物学,使科学家能够理解和识别生物数据中的模式。它在研究基因组和 DNA 测序方面特别有用,因为它允许科学家组织大量数据。

从遗传学到毒理学再到真菌学和放射生物学,生物学有许多分支学科可供研究。在众多分支学科中,生物信息学是最有趣的领域之一,它能让你识别、评估、存储和检索生物信息。作为一个跨学科的研究领域,它结合了计算机科学、统计学和生物学的各种应用,开发用于理解生物数据的软件应用程序,如 DNA 测序、蛋白质分析、进化遗传学等。

  • 在不久的将来,与药物发现的生物信息学相关的重要决策将由那些不仅了解生物学,而且还能使用生物信息学工具及其发布的知识来制定假设和确定质量目标的个人来做出。

欧洲生物信息学市场动态

驱动程序

  • 主要参与者提供广泛的产品组合

主要参与者在生物信息学领域的进步和不断增长的研究使他们能够开发和在市场上推出新产品。不同的测序仪器存在于生物信息学市场中。

例如,

  • QIAGEN 的产品组合包括生物信息学产品和服务,例如定制自动化工作流程、管理服务和可扩展的生物信息学服务
  • BGI 包括测序服务和质谱服务,例如蛋白质组学、代谢组学、多组学和生物制剂表征
  • Eurofins Scientific 的基因合成和分子生物学提供基因合成和分子生物学产品

因此,在这个市场中运营的公司的产品组合非常庞大,因此这些公司的收入比过去最近的收入年度持续增长。预计这将推动市场规模扩大,并有望在预测期内成为生物信息学市场的驱动力

  • 对生物信息学的需求日益增长

随着以基因组学为重点的药理学在治疗各种慢性疾病(尤其是癌症)方面发挥着越来越重要的作用,新一代测序 (NGS) 正在发展成为一种强大的工具,可以更深入、更准确地了解单个肿瘤和特定受体的分子基础。信息学在涉及学习编程的生物学家、计算机程序员、数学家或学习生物学基础知识的数据库管理员的生物学研究中至关重要

例如,

  • NGS 还被用于全面分析与药物药代动力学和药效学相关的药物遗传学。2017 年的一份初步报告表明,这项技术可能是一种可靠而有效的工具,可用于发现这些基因中常见和罕见的遗传变异
  • 生物信息学是利用计算和分析工具来捕获和解释生物数据

生物信息学有能力改变肿瘤学的前景,并通过采用以基因组为中心的药理学来治疗慢性疾病,推动精准医疗的愿景。因此,以基因组为中心的药理学在慢性疾病治疗中的应用增加,成为生物信息学市场发展的驱动力。

机会

  • 生物信息学在个性化医疗中的应用

生物信息学市场临床应用的增长曲线呈上升趋势,因为现有应用正在获得发展势头,而新应用正在找到立足点。过去几年的产品开发帮助市场规模增长。这也表明监管机构支持允许这些产品进入市场。

  • 市场参与者的战略举措

生物信息学提供有目的的生物信息,因为它是生命科学的一部分,涉及基因组的理解和规划。基因组是存在于细胞或整个生物体中的遗传集的复杂排列。个性化医疗是一种处理个人特定医疗保健的组合方式。患者特定药物的开发通过生物信息学工具得到推进。

例如-

  • 2020 年 12 月,Quest Diagnostics Incorporated 投资了计算蛋白质组学和结构药物基因组学领域的领导者 Structural Bioinformatics。该投资促成了一系列新型结构变异蛋白质的数据库模块的联合开发,并将这些产品直接销售给制药和生物技术行业,用于个性化医疗的开发
  • 2019 年,华大基因宣布 Flow Pharma 选择华大基因(华大基因集团子公司)开发 NSG 在药物开发中的应用

因此,慢性病的日益流行和传统药物耐药性问题的加剧,催生了药物开发中生物信息学应用的需求。这有望成为预测期内推动市场增长的主要因素之一。

限制/挑战

  • 临床生物信息学分析的难点

大数据分析的潜力尚未得到充分开发,这一话题随着大量下一代数据集的产生而愈演愈烈,这些数据集旨在解答人类疾病生物学方面的长期问题。尽管这些方法可能是揭示新生物学见解的有力手段,但目前有几个重大挑战阻碍了利用大数据的力量。典型的挑战包括有效评估分析软件工具、使用混合并行计算 (HPC) 并行化和加速技术加快整个过程、自动化策略的进步、数据存储替代方案,以及最终开发新方法以充分利用多种实验条件下的结果。

考虑到某些生物信息学测试的重要性尚不确定,它们不能替代仔细的临床评估。通过促进数据共享和直接交换与表型相关的选定变异,这可能会大大增强对基因变异的分析。因此,临床生物信息学的难度预计将抑制市场增长。

  • 生物信息学中的网络安全问题

众所周知,Era 软件包含由不完善的代码和错误配置引起的漏洞。用于操作测序和实验室设备或进行生物信息学分析的 NGS 相关软件也不例外。软件漏洞被用来未经授权访问计算机系统或网络、泄露数据、导致崩溃或以其他方式破坏各种服务。

然而,DNA 技术和生物技术日益计算机化,引发了新的生物网络安全问题。传统计算机系统通常存在的漏洞(如处理不受信任的输入、侧信道泄漏、身份验证不充分、数据造假以及网络物理系统中的漏洞)现在也存在于生物技术中。新兴的生物网络安全威胁已经威胁到生物信息学中的 DNA 信息系统。

例如;

  • 2020 年,REvil 或 Sodinokibi 勒索软件组织因入侵并窃取 10x Genomics 用于 COVID-19 研究的 1 兆字节 (TB) 数据而受到赞誉
  • 2018 年,英国基因组学公司在遭到外国网络攻击后,转移了其 100,000 人基因组计划的基因蓝图数据。这导致数据泄露,并可能导致个人基因组的滥用

COVID-19 对欧洲生物信息学市场的影响

在疫情期间,欧洲生物信息学行业专注于结合使用生物学和信息技术。该行业的核心是生物数据,使用 IT 技术对其进行分析和转换。生物信息学在为许多科学研究领域提供必要支持方面一直具有巨大潜力。生物信息学可以提供的工具使科学家能够掌握更大的数据集并对其进行挖掘和分析,以发现可能导致关键发现的关键信息。近年来,遗传学和基因组一直是生物信息学的主要关注点,包括比较基因组学、DNA 微阵列和功能基因组学。

近期发展

  • 2022 年 3 月,赛默飞世尔科技公司推出了用于临床实验室的 CE-IVD 标记的下一代测序 (NGS) 仪器。CE-IVD 标记的下一代测序仪器用于在单个仪器上进行诊断测试和临床研究。该仪器的推出导致产品系列中增加了一款新产品,并分销了 NGS 仪器,预计将增加产品收入。

欧洲生物信息学市场范围

欧洲生物信息学市场根据六个部分进行细分:类型、行业、应用、购买模式、基因组学和最终用户。这些部分之间的增长将帮助您分析行业中增长微弱的部分,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,以确定核心市场应用。

类型

  • 知识管理工具
  • 生物信息学软件
  • 服务

根据类型,欧洲生物信息学市场分为知识管理工具、生物信息学软件和服务。

部门

  • 医药生物技术
  • 学术
  • 动物生物技术
  • 农业生物技术
  • 环境生物技术
  • 法医生物技术
  • 其他的

根据行业划分,欧洲生物信息学市场分为医学生物技术、学术、动物生物技术、农业生物技术、环境生物技术、法医生物技术等。

应用

  • 基因组学和药物开发
  • 蛋白质组学
  • 进化研究
  • 农业研究
  • 兽医学
  • 代谢组学
  • 转录组学
  • 其他的

根据应用,欧洲生物信息学市场分为基因组学和药物开发、蛋白质组学、进化研究、农业研究、兽医学、代谢组学、转录组学等。

购买方式

  • 团购
  • 个人购买

根据购买模式,欧洲生物信息学市场分为团体购买和个人购买。

方法

  • 基因组学
  • 蛋白质组学

根据方法,欧洲生物信息学市场分为基因组学和蛋白质组学。

最终用户

  • 研究与学术机构
  • 临床研究组织
  • 生物科技和制药公司
  • 研究实验室
  • 医院
  • 其他的

生物信息学市场

根据最终用户,欧洲生物信息学市场分为研究和学术机构、临床研究组织、生物技术和制药公司、研究实验室、医院等。

欧洲生物信息学市场区域分析/见解

对欧洲生物信息学市场进行了分析,并按地区、类型、部门、应用、购买模式、基因组学和最终用户提供了市场规模洞察和趋势。如上所述。

欧洲生物信息学市场报告涵盖的国家包括德国、法国、英国、意大利、俄罗斯、西班牙、瑞士、荷兰、比利时、土耳其和欧洲其他地区。

由于人们对生物信息学测序认识的提高,预计德国将主导市场,并且德国公司和生物信息学研究机构之间的合作数量的增加预计将推动市场增长。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化,这些因素和法规变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了品牌的存在和可用性以及由于来自本地和国内品牌的大量或稀缺竞争而面临的挑战,这些品牌影响销售渠道。

竞争格局和欧洲生物信息学市场份额分析

欧洲生物信息学市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、欧洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对欧洲生物信息学市场的关注有关。

欧洲生物信息学市场的一些主要参与者包括赛默飞世尔科技公司、Illumina 公司、安捷伦科技公司、QIAGEN、SOPHiA GENETICS、BGI、Eurofins Scientific、Waters 公司、Dassault Systèmes、拜耳公司、PerkinElmer 公司、Seven Bridges Genomics、Quest Diagnostics Incorporated、AstridBio Technologies 公司、BioBam 和 GenoFAB 公司。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE BIOINFORMATICS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHIC SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 RESEARCH METHODOLOGY

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MULTIVARIATE MODELLING

2.8 TYPE SEGMENT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 THE CATEGORY VS TIME GRID

2.13 SECONDARY SOURCES

2.14 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL

4.2 PORTER'S FIVE FORCES MODEL

5 REGULATIONS OF THE EUROPE BIOINFORMATICS MARKET

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 DECREASE IN THE COST OF GENETIC SEQUENCING PER BASE

6.1.2 GROWING NEED FOR BIOINFORMATICS

6.1.3 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS

6.1.4 USE OF BIOINFORMATICS IN PERSONALIZED MEDICINE

6.1.5 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS

6.2 RESTRAINTS

6.2.1 HIGH COST OF INSTRUMENTATION

6.2.2 DIFFICULTY IN CLINICAL BIOINFORMATICS ANALYSIS

6.2.3 CYBER SECURITY CONCERNS IN BIOINFORMATICS

6.3 OPPORTUNITIES

6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER

6.3.2 PRODUCT DEVELOPMENT IN RECENT YEARS

6.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY

6.4 CHALLENGES

6.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM BIOINFORMATICS TECHNOLOGY

6.4.2 CHALLENGES TO IMPLEMENTING BIOINFORMATICS TECHNOLOGY IN THE CLINICAL LABS

7 EUROPE BIOINFORMATICS MARKET, BY TYPE

7.1 OVERVIEW

7.2 SERVICES

7.2.1 DIAGNOSTICS CONSULTATION

7.2.2 DATA ANALYSIS

7.2.2.1 STRUCTURAL

7.2.2.2 FUNCTIONAL

7.3 BIOINFORMATICS SOFTWARE

7.3.1 INFORMATICS INFRASTRUCTURE AND PIPELINE SETUP

7.3.2 SAMPLE AND EXPERIMENT MANAGEMENT

7.3.3 SEQUENCING DATA ANALYSIS

7.3.3.1 SEQUENCE ANALYSIS PLATFORM

7.3.3.2 SEQUENCE ALIGNMENT PLATFORM

7.3.3.3 SEQUENCE MANIPULATION PLATFORM

7.3.3.4 STRUCTURAL ANALYSIS PLATFORM

7.3.3.5 OTHERS

7.3.4 BIOLOGICAL DATA INTERPRETATION

7.3.5 SPECIALIZED BIOINFORMATICS APPLICATIONS

7.3.5.1 SINGLE CELL GENE EXPRESSION

7.3.5.2 GENE EXPRESSION

7.3.5.3 VARIANT DETECTION

7.3.5.4 CNV ANALYSIS

7.3.5.5 METAGENOMICS

7.3.5.6 METHYLATION

7.3.5.7 CHIP-SEQ

7.3.5.8 NON-CODING RNA EXPRESSION

7.3.5.9 OTHERS

7.3.6 OTHERS

7.4 KNOWLEDGE MANAGEMENT TOOLS

7.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS

7.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS

8 EUROPE BIOINFORMATICS MARKET, BY SECTOR

8.1 OVERVIEW

8.2 MEDICAL BIOTECHNOLOGY

8.3 ACADEMICS

8.4 ANIMAL BIOTECHNOLOGY

8.5 AGRICULTURAL BIOTECHNOLOGY

8.6 ENVIRONMENTAL BIOTECHNOLOGY

8.7 FORENSIC BIOTECHNOLOGY

8.8 OTHERS

9 EUROPE BIOINFORMATICS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 GENOMICS & DRUG DEVELOPMENT

9.2.1 SERVICES

9.2.2 SEQUENCING PLATFORMS

9.2.3 KNOWLEDGE MANAGEMENT TOOLS

9.2.4 GENOMICS & DRUG DEVELOPMENT BY TYPE

9.2.4.1 PREVENTIVE MEDICINE

9.2.4.2 MOLECULAR MEDICINE

9.2.4.3 PERSONALIZED MEDICINE

9.2.4.4 CHEMOINFORMATICS AND DRUG DESIGN

9.2.4.5 ANTIBIOTIC RESISTANCE

9.3 PROTEOMICS

9.3.1 SERVICES

9.3.2 SERVICES SEQUENCING PLATFORMS

9.3.3 KNOWLEDGE MANAGEMENT TOOLS

9.4 AGRICULTURAL STUDIES

9.4.1 SERVICES

9.4.2 SERVICES SEQUENCING PLATFORMS

9.4.3 KNOWLEDGE MANAGEMENT TOOLS

9.5 TRANSCRIPTOMICS

9.5.1 SERVICES

9.5.2 SERVICES SEQUENCING PLATFORMS

9.5.3 KNOWLEDGE MANAGEMENT TOOLS

9.6 METABOLOMICS

9.6.1 SERVICES

9.6.2 SERVICES SEQUENCING PLATFORMS

9.6.3 KNOWLEDGE MANAGEMENT TOOLS

9.7 EVOLUTIONARY STUDIES

9.7.1 SERVICES

9.7.2 SERVICES SEQUENCING PLATFORMS

9.7.3 KNOWLEDGE MANAGEMENT TOOLS

9.8 VETERINARY SCIENCE

9.8.1 SERVICES

9.8.2 SERVICES SEQUENCING PLATFORMS

9.8.3 KNOWLEDGE MANAGEMENT TOOLS

9.9 OTHERS

9.9.1 SERVICES

9.9.2 SERVICES SEQUENCING PLATFORMS

9.9.3 KNOWLEDGE MANAGEMENT TOOLS

10 EUROPE BIOINFORMATICS MARKET, BY PURCHASE MODE

10.1 OVERVIEW

10.2 GROUP PURCHASE

10.3 INDIVIDUAL PURCHASE

11 EUROPE BIOINFORMATICS MARKET, BY METHOD

11.1 OVERVIEW

11.2 GENOMICS

11.2.1 DNA

11.2.2 RNA

11.3 PROTEOMICS

12 EUROPE BIOINFORMATICS MARKET, BY END USER

12.1 OVERVIEW

12.2 RESEARCH AND ACADEMIC INSTITUTES

12.3 CLINICAL RESEARCH ORGANIZATION

12.4 BIOTECH AND PHARMACEUTICAL COMPANIES

12.5 RESEARCH LABORATORIES

12.6 HOSPITALS

12.7 OTHERS

13 EUROPE BIOINFORMATICS MARKET, BY REGION

13.1 EUROPE

13.1.1 GERMANY

13.1.2 FRANCE

13.1.3 U.K.

13.1.4 ITALY

13.1.5 RUSSIA

13.1.6 SPAIN

13.1.7 SWITZERLAND

13.1.8 NETHERLANDS

13.1.9 BELGIUM

13.1.10 TURKEY

13.1.11 REST OF EUROPE

14 EUROPE BIOINFORMATICS MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: EUROPE

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 BAYER AG

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 THERMO FISHER SCIENTIFIC INC

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 EUROFINS SCIENTIFIC

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 DASSAULT SYSTÈMES

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENTS

16.5 AGILENT TECHNOLOGIES, INC

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENTS

16.6 ASTRIDBIO TECHNOLOGIES INC.

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENTS

16.7 BGI (A SUBSIDIARY OF BGI GROUP)

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 BIOBAM

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENTS

16.9 DNANEXUS INC.

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENTS

16.1 DNASTAR

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENTS

16.11 GENOFAB, INC

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 ILLUMINA, INC

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENTS

16.13 PARTEK INCORPORATED

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENTS

16.14 PERKINELMER INC.

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENTS

16.15 QIAGEN

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.16 QUEST DIAGNOSTICS INCORPORATED (2021)

16.16.1 COMPANY SNAPSHOT

16.16.2 REVENUE ANALYSIS

16.16.3 PRODUCT PORTFOLIO

16.16.4 RECENT DEVELOPMENTS

16.17 SEVEN BRIDGES GENOMICS

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 SOPHIA GENETICS

16.18.1 COMPANY SNAPSHOT

16.18.2 REVENUE ANALYSIS

16.18.3 PRODUCT PORTFOLIO

16.18.4 RECENT DEVELOPMENTS

16.19 STRAND LIFE SCIENCES

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 WATERS CORPORATION

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

表格列表

TABLE 1 BIOINFORMATICSCOST PER SAMPLE

TABLE 2 EUROPE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 3 EUROPE SERVICES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 EUROPE SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 5 EUROPE DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 6 EUROPE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 EUROPE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 8 EUROPE SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 9 EUROPE SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 10 EUROPE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 EUROPE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 13 EUROPE MEDICAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 EUROPE ACADEMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 EUROPE ANIMAL TECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 EUROPE AGRICULTURAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 EUROPE ENVIRONMENTAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 EUROPE FORENSIC BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 21 EUROPE GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 EUROPE GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 23 EUROPE GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 24 EUROPE PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 EUROPE PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 26 EUROPE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 EUROPE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 28 EUROPE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 EUROPE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 30 EUROPE METABOLOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 EUROPE METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 32 EUROPE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 EUROPE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 34 EUROPE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 EUROPE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 36 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 38 EUROPE BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 39 EUROPE GROUP PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 EUROPE INDIVIDUAL PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 EUROPE BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 42 EUROPE GENOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 EUROPE GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 44 EUROPE PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 EUROPE BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 46 EUROPE RESEARCH AND ACADEMIC INSTITUTES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 47 EUROPE CLINICAL RESEARCH ORGANIZATION IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 48 EUROPE BIOTECH AND PHARMACEUTICAL COMPANIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 49 EUROPE RESEARCH LABORATORIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 50 EUROPE HOSPITALS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 52 EUROPE BIOINFORMATICS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 53 EUROPE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 EUROPE SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 55 EUROPE DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 56 EUROPE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 57 EUROPE SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 58 EUROPE SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 59 EUROPE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 60 EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 61 EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 62 EUROPE GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 63 EUROPE GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 64 EUROPE PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 65 EUROPE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 66 EUROPE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 67 EUROPE METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 68 EUROPE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 69 EUROPE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 70 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 71 EUROPE BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 72 EUROPE BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 73 EUROPE GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 74 EUROPE BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 75 GERMANY BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 76 GERMANY SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 77 GERMANY DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 78 GERMANY BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 79 GERMANY SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 80 GERMANY SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 81 GERMANY KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 82 GERMANY BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 83 GERMANY BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 84 GERMANY GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 85 GERMANY GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 86 GERMANY PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 87 GERMANY AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 88 GERMANY TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 89 GERMANY METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 90 GERMANY EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 91 GERMANY VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 92 GERMANY OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 93 GERMANY BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 94 GERMANY BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 95 GERMANY GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 96 GERMANY BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 97 FRANCE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 98 FRANCE SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 99 FRANCE DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 100 FRANCE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 101 FRANCE SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 FRANCE SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 103 FRANCE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 FRANCE BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 105 FRANCE BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 106 FRANCE GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 107 FRANCE GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 108 FRANCE PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 109 FRANCE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 110 FRANCE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 111 FRANCE METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 112 FRANCE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 113 FRANCE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 114 FRANCE OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 115 FRANCE BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 116 FRANCE BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 117 FRANCE GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 118 FRANCE BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 119 U.K. BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 120 U.K. SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 121 U.K. DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 122 U.K. BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 123 U.K. SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 124 U.K. SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 125 U.K. KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 126 U.K. BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 127 U.K. BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 128 U.K. GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 129 U.K. GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 130 U.K. PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 131 U.K. AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 132 U.K. TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 133 U.K. METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 134 U.K. EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 135 U.K. VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 136 U.K. OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 137 U.K. BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 138 U.K. BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 139 U.K GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 140 U.K. BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 141 ITALY BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 142 ITALY SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 143 ITALY DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 144 ITALY BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 145 ITALY SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 146 ITALY SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 147 ITALY KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 148 ITALY BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 149 ITALY BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 150 ITALY GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 151 ITALY GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 152 ITALY PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 153 ITALY AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 154 ITALY TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 155 ITALY METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 156 ITALY EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 157 ITALY VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 158 ITALY OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 159 ITALY BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 160 ITALY BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 161 ITALY GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 162 ITALY BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 163 RUSSIA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 164 RUSSIA SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 165 RUSSIA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 166 RUSSIA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 167 RUSSIA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 168 RUSSIA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 169 RUSSIA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 170 RUSSIA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 171 RUSSIA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 172 RUSSIA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 173 RUSSIA GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 174 RUSSIA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 175 RUSSIA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 176 RUSSIA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 177 RUSSIA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 178 RUSSIA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 179 RUSSIA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 180 RUSSIA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 181 RUSSIA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 182 RUSSIA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 183 RUSSIA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 184 RUSSIA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 185 SPAIN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 186 SPAIN SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 187 SPAIN DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 188 SPAIN BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 189 SPAIN SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 190 SPAIN SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 191 SPAIN KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 192 SPAIN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 193 SPAIN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 194 SPAIN GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 195 SPAIN GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 196 SPAIN PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 197 SPAIN AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 198 SPAIN TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 199 SPAIN METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 200 SPAIN EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 201 SPAIN VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 202 SPAIN OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 203 SPAIN BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 204 SPAIN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 205 SPAIN GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 206 SPAIN BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 207 SWITZERLAND BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 208 SWITZERLAND SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 209 SWITZERLAND DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 210 SWITZERLAND BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 211 SWITZERLAND SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 212 SWITZERLAND SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 213 SWITZERLAND KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 214 SWITZERLAND BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 215 SWITZERLAND BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 216 SWITZERLAND GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 217 SWITZERLAND GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 218 SWITZERLAND PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 219 SWITZERLAND AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 220 SWITZERLAND TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 221 SWITZERLAND METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 222 SWITZERLAND EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 223 SWITZERLAND VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 224 SWITZERLAND OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 225 SWITZERLAND BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 226 SWITZERLAND BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 227 SWITZERLAND GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 228 SWITZERLAND BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 229 NETHERLANDS BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 230 NETHERLANDS SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 231 NETHERLANDS DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 232 NETHERLANDS BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 233 NETHERLANDS SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 234 NETHERLANDS SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 235 NETHERLANDS KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 236 NETHERLANDS BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 237 NETHERLANDS BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 238 NETHERLANDS GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 239 NETHERLANDS GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 240 NETHERLANDS PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 241 NETHERLANDS AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 242 NETHERLANDS TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 243 NETHERLANDS METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 244 NETHERLANDS EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 245 NETHERLANDS VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 246 NETHERLANDS OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 247 NETHERLANDS BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 248 NETHERLANDS BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 249 NETHERLANDS GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 250 NETHERLANDS BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 251 BELGIUM BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 252 BELGIUM SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 253 BELGIUM DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 254 BELGIUM BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 255 BELGIUM SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 256 BELGIUM SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 257 BELGIUM KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 258 BELGIUM BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 259 BELGIUM BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 260 BELGIUM GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 261 BELGIUM GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 262 BELGIUM PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 263 BELGIUM AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 264 BELGIUM TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 265 BELGIUM METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 266 BELGIUM EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 267 BELGIUM VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 268 BELGIUM OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 269 BELGIUM BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 270 BELGIUM BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 271 BELGIUM GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 272 BELGIUM BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 273 TURKEY BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 274 TURKEY SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 275 TURKEY DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 276 TURKEY BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 277 TURKEY SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 278 TURKEY SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 279 TURKEY KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 280 TURKEY BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 281 TURKEY BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 282 TURKEY GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 283 TURKEY GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 284 TURKEY PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 285 TURKEY AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 286 TURKEY TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 287 TURKEY METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 288 TURKEY EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 289 TURKEY VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 290 TURKEY OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 291 TURKEY BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 292 TURKEY BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 293 TURKEY GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 294 TURKEY BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 295 REST OF EUROPE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 EUROPE BIOINFORMATICS MARKET: SEGMENTATION

FIGURE 2 EUROPE BIOINFORMATICS MARKET: GEOGRAPHIC SCOPE

FIGURE 3 EUROPE BIOINFORMATICS MARKET: DATA TRIANGULATION

FIGURE 4 EUROPE BIOINFORMATICS MARKET: SNAPSHOT

FIGURE 5 EUROPE BIOINFORMATICS MARKET: BOTTOM-UP APPROACH

FIGURE 6 EUROPE BIOINFORMATICS MARKET: TOP-DOWN APPROACH

FIGURE 7 EUROPE BIOINFORMATICS MARKET: INTERVIEWS BY REGION AND DESIGNATION

FIGURE 8 EUROPE BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE BIOINFORMATICS MARKET: APPLICATION COVERAGE GRID

FIGURE 11 EUROPE BIOINFORMATICS MARKET: THE CATEGORY VS TIME GRID

FIGURE 12 EUROPE BIOINFORMATICS MARKET SEGMENTATION

FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE EUROPE DENTAL LABMARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 GROWING APPLICATIONS OF BIOINFORMATICS AND LOW COST OF BIOINFORMATICS SEQUENCING ARE EXPECTED TO DRIVE THE MARKET FOR EUROPE BIOINFORMATICS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 15 SERVICES SEGMENT ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE BIOINFORMATICS MARKET IN 2019 & 2026

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE BIOINFORMATICS MARKET

FIGURE 17 DECREASE IN COST OF PER BASE SEQUENCING

FIGURE 18 GROWING NEED FOR BIOINFORMATICS IN VITAL APPLICATIONS

FIGURE 19 EUROPE BIOINFORMATICS MARKET: BY TYPE, 2021

FIGURE 20 EUROPE BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 21 EUROPE BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 22 EUROPE BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 23 EUROPE BIOINFORMATICS MARKET: BY SECTOR, 2021

FIGURE 24 EUROPE BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)

FIGURE 25 EUROPE BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)

FIGURE 26 EUROPE BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE

FIGURE 27 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, 2021

FIGURE 28 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 29 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 30 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 31 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, 2021

FIGURE 32 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, 2022-2029 (USD MILLION)

FIGURE 33 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, CAGR (2022-2029)

FIGURE 34 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, LIFELINE CURVE

FIGURE 35 EUROPE BIOINFORMATICS MARKET: BY METHOD, 2021

FIGURE 36 EUROPE BIOINFORMATICS MARKET: BY METHOD, 2022-2029 (USD MILLION)

FIGURE 37 EUROPE BIOINFORMATICS MARKET: BY METHOD, CAGR (2022-2029)

FIGURE 38 EUROPE BIOINFORMATICS MARKET: BY METHOD, LIFELINE CURVE

FIGURE 39 EUROPE BIOINFORMATICS MARKET: BY END USER, 2021

FIGURE 40 EUROPE BIOINFORMATICS MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 41 EUROPE BIOINFORMATICS MARKET: BY END USER, CAGR (2022-2029)

FIGURE 42 EUROPE BIOINFORMATICS MARKET: BY END USER, LIFELINE CURVE

FIGURE 43 EUROPE BIOINFORMATICS MARKET: SNAPSHOT (2021)

FIGURE 44 EUROPE BIOINFORMATICS MARKET: BY COUNTRY (2021)

FIGURE 45 EUROPE BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 46 EUROPE BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 47 EUROPE BIOINFORMATICS MARKET: BY TYPE (2022-2029)

FIGURE 48 EUROPE BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Type (Knowledge Management Tools, Bioinformatics Software and Services), Sector (Medical Biotechnology, Academics, Animal Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Others), Application (Genomics & Drug Development, Proteomics, Evolutionary Studies, Agricultural Studies, Veterinary Science, Metabolomics, Transcriptomics and Others), Purchase Mode (Group Purchase and Individual Purchase), Method (Genomics and Proteomics) End-User, (Research and Academic Institutes, Clinical Research Organization, Biotech and Pharmaceutical Companies, Research Laboratories, Hospital and Others) - Industry Trends and Forecast to 2029. .
The Europe Bioinformatics Market size was valued at USD 0.00 USD Million in 2022.
The Europe Bioinformatics Market is projected to grow at a CAGR of 19.5% during the forecast period of 2023 to 2029.
The major players operating in the market include Thermo Fisher Scientific , Illumina , Agilent Technologies , QIAGEN, SOPHiA GENETICS, BGI, Eurofins Scientific, Waters Corporation, Dassault Systèmes, Bayer AG, PerkinElmer , Seven Bridges Genomics, Quest Diagnostics ,orporated, AstridBio Technologies , BioBam, and GenoFAB ,.
The market report covers data from the Germany, France, U.K., Italy,  Russia, Spain, Switzerland, Netherlands, Belgium, Turkey, Rest of Europe.